SCHEMBL7873634

SCHEMBL7873634

CCCCOC(=O)NC(C)c1cccc(N)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.47
SMN1; SMN2 Q16637 7/20 0.47
NPC1 O15118 6/20 0.47
LMNA P02545 3/20 0.47
HPGD P15428 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ACACB O00763 2/20 0.43
POLB P06746 2/20 0.43
MAPK1 P28482 1/20 0.43
ACACA Q13085 1/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
PDE4D Q08499 1/20 0.43
CTSK P43235 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14714268 0.90 ADRB2 (0.39) RAB9ASMN1; SMN2NPC1LMNAMAPK1
SCHEMBL30344053 0.85 ALDH1A1 (0.50) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL9317172 0.84 POLB (0.58) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL8240521 0.80 ATM (0.56) SMN1; SMN2LMNAPOLBCYP1A2CYP2C9
SCHEMBL27733208 0.80 ATM (0.56) SMN1; SMN2LMNAPOLBCYP1A2CYP2C9
SCHEMBL8241135 0.80 ATM (0.56) SMN1; SMN2LMNAPOLBCYP1A2CYP2C9
SCHEMBL4448687 0.79 SMN1; SMN2 (0.52) RAB9ASMN1; SMN2NPC1HPGDL3MBTL1
SCHEMBL16054984 0.79 ACACB (0.50) ACACBPOLBACACACTSK
SCHEMBL11632696 0.77 LMNA (0.46) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL16055604 0.77 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2NPC1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1067928-A4 METHODS FOR INHIBITING MRP1 LILLY CO ELI (US) 2001-11-14 EP disclosed
EP-1067928-A1 METHODS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2001-01-17 EP disclosed
WO-1999051228-A1 METHODS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 1999-10-14 WO disclosed